SSA
ZJYL

Schonfeld Strategic Advisors’s Jin Medical International ZJYL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ZJYL Stock Details ZJYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-510
Closed -$27.4K – 2458
2024
Q3 		$27.4K Sell
510
-130
-20% -$7.82K ﹤0.01% 1912
2024
Q2 		$33.3K Sell
640
-855
-57% -$54.1K ﹤0.01% 1973
2024
Q1 		$115K Buy
+1,495
New +$219K ﹤0.01% 1840

Other funds holding ZJYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIA
Bell Investment Advisors Oakland, California $639M AUM 13.28% 1-Year Est. Return
W
WealthCollab Bellevue, Washington $243M AUM 32.93% 1-Year Est. Return

Schonfeld Strategic Advisors's ZJYL Position: Q4 2024 in Review

Schonfeld Strategic Advisors sold out of Jin Medical International (ZJYL) in Q4 2024, closing a stake of 510 shares — an estimated $27.4K sold.

Schonfeld Strategic Advisors first reported a position in ZJYL in Q1 2024 and held it in 3 quarters. The position peaked at $115K in Q1 2024. 10 funds tracked by Wall St. Rank hold ZJYL as of Q4 2024.

  • Schonfeld Strategic Advisors reported no remaining Jin Medical International position as of Q4 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 510 Jin Medical International shares in Q4 2024, an estimated $27.4K.
  • Schonfeld Strategic Advisors first reported a position in Jin Medical International in Q1 2024 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Jin Medical International position peaked at $115K in Q1 2024.
  • 10 funds tracked by Wall St. Rank held Jin Medical International as of Q4 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.